Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 10 | |
Hold | 6 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 20 analysts offering 12 month price targets for Tandem Diabetes Care Inc have a median target of 56.50, with a high estimate of 75.00 and a low estimate of 18.00. The median estimate represents a 83.80% increase from the last price of 30.74.
High | 144.0% | 75.00 |
Med | 83.8% | 56.50 |
Low | -41.4% | 18.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 19, 2025.
Average growth rate | -14.64% |
Average growth rate | -21.09% |
More ▼
Revenue history & estimates in USD
Average growth rate | +7.28% |
Average growth rate | +21.47% |
More ▼